Welcome to our web site!

Our passion for quality and attention to details is evident in the time. The manufacturing and quality are licensed and supervised by Bolise. Bolise Co., Ltd. is biotech laboratories founded in Australia and China in 2001. We focus on research and development of innovative Acridine Raw Material, Pharmaceutical Raw Materials, Pharmaceutical Chemicals.......   >>>Read More

We have satisfied customers from all around the world, including:

You are here: Bolise NewsViews

Introduction of (R)-(-)-1-Aminoindane


  A practical asymmetric synthesis of nearly enantiomerically pure (R)-(-)-1-Aminoindane has been developed. The key step involves the diastereoselective heterogeneous metal-catalyzed reduction of the ketimine of 1-indanone with the chiral auxiliary (R)-phenylglycine amide. The selectivity of the asymmetric hydrogenation step was optimized with regard to metal catalyst, solvent and catalyst loading. The chiral auxiliary was removed by means of a novel non-reductive procedure. Thus, (R)-(-)-1-Aminoindane with an ee of 96% was prepared in 58% overall yield from (R)-phenylglycine amide in an effective three-step procedure.